Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
RSS icon
Thumbnail

Machine learning tool aids radiologists in IDing cancerous breast lesions

Researchers at the Massachusetts Institute of Technology (MIT)'s Computer Science and Artificial Intelligence Laboratory and breast imaging experts at Massachusetts General Hospital (MGH) have developed a machine learning tool capable of identifying high-risk breast lesions that are likely to become cancerous. The tool aims to reduce the amount of unnecessary surgeries in patients with low-risk lesions.

Thumbnail

Teleneurology curriculum outlines 5 points for improved care

Teleneurology, while a potentially effective route in delivering quality neurological care to remote patients, remains unregulated in medical education. In response, a researcher from the University of Missouri School of Medicine and a team at the American Academy of Neurology (AAN) developed a teleneurology curriculum.

Apple reportedly explored medical clinic acquisition

CNBC reported Apple was in talks to buy Crossover Health, a Aliso Viejo, California-based startup that works with large, self-insured employers to run medical clinics on their campuses, though the discussions never resulted in an acquisition.

Vermont expanding Medicaid ACO program

Vermont OneCare, its accountable care organization (ACO) model for Medicaid beneficiaries, will expand to include Medicare patients and those covered by private insurance in 2018.

BIOLIFE4D Appoints Texas Heart Institute Surgeon Dr. Jeffrey Morgan Chief Medical Officer, Bolstering Leadership Team

Bioprinting startup BIOLIFE4D named accomplished thoracic and cardiac surgeon Jeffrey Morgan M.D., FACS, FACC as Chief Medical Officer, further bolstering its world-class leadership team. BIOLIFE4D is a pioneering biotech company focused on leveraging advances in life sciences and tissue engineering to 3D bioprint a viable human heart suitable for transplant.

Thumbnail

Come together: 5 things to know about forming a virtual group in MIPS

The second year of the Merit-based Incentive Payment System (MIPS) has proposed new option for participation, with clinicians able to join together in “virtual groups” to report on MIPS performance measures.

Surgical glue closes wounds in 60 seconds, can be programmed to stay sealed for months

Biomedical engineers from the University of Sydney and the United States have developed an elastic and adhesive surgical glue capable of sealing wounds in 60 seconds. Finding are explained in Science Translational Medicine.

Mobile apps aim to treat AFib

Heart experts have developed a pair of mobile health applications to treat atrial fibrillation (AFib). The pair of apps, AF Manager and My AF, are tailored to providers and patients to offer a more comprehensive care experience using different but linked platforms.

Displaying 1657 - 1664 of 3584

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup